drugset / Trial / NCT05320367

A Study of Inhaled Cannabidiol in Healthy Occasional Cannabis Users

NCT05320367 ↗

Phase 1/2 Not yet recruiting 80 enrolled University of Montreal Hospital Centre (CHUM)
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purposes of this study are 1) to determine if the administration of different low doses of CBD (5 mg, 20 mg, 50 mg and 100 mg) result in detectable subjective pleasant drug effect compared to placebo and 2) to qualitatively explore whether low dose CBD is associated with effects that are not detected with the available research tools.

Timeline

Start
2026-09
Primary completion
2027-10
Completion
2027-12

Drugs

EvaluationDrugModalityDoseRoute
Subject CBD Unknown 5 mg Inhaled
Subject CBD Unknown 20 mg Inhaled
Subject CBD Unknown 50 mg Inhaled
Subject CBD Unknown 100 mg Inhaled

Indications

No indication recorded.